Abstract
Elevated arterial pulse pressure (PP) and blood pressure (BP) can lead to atrophy of cerebral white matter (WM), potentially due to shared genetic factors. We calculated the magnitude of shared genetic variance between BP and fractional anisotropy (FA) of water diffusion, a sensitive measurement of WM integrity in a well-characterized population of Mexican-Americans. The patterns of whole-brain and regional genetic overlap between BP and FA were interpreted in the context the pulse-wave encephalopathy (PWE) theory. We also tested whether regional pattern in genetic pleiotropy is modulated by the phylogeny of WM development. BP and high-resolution (1.7×1.7×3mm, 55 directions) diffusion tensor imaging (DTI) data were analyzed for 332 (202 females; mean age=47.9±13.3years) members of the San Antonio Family Heart Study. Bivariate genetic correlation analysis was used to calculate the genetic overlap between several BP measurements [PP, systolic (SBP) and diastolic (DBP)] and FA (whole-brain and regional values). Intersubject variance in PP and SBP exhibited a significant genetic overlap with variance in whole-brain FA values, sharing 36% and 22% of genetic variance, respectively. Regionally, shared genetic variance was significantly influenced by rates of WM development (r=−.75, p=0.01). The pattern of genetic overlap between BP and WM integrity was generally in-agreement with the PWE theory. Our study provides evidence that a set of pleiotropically acting genetic factors jointly influence phenotypic variation in BP and WM integrity. The magnitude of this overlap appears to be influenced by phylogeny of WM development suggesting a possible role for genotype-by-age interactions.
Keywords: Population science, genetics, blood pressure, pulse pressure, white matter integrity, fractional anisotropy, diffusion tensor imaging, DTI
Background and Purpose
Elevated blood pressure (BP) is a well-known risk factor for atrophy of cerebral white matter (WM) and this can lead to cognitive decline and disability in the elderly1. BP and the integrity of cerebral WM are under strong genetic control, with up to 80% of individual variance explained by genetic factors2–8. We hypothesized that the genetic factors responsible for elevation in BP were also responsible for decline in white WM integrity. This hypothesis was tested in a well-characterized population Mexican-Americans randomly selected from large extended families9. WM integrity was gauged as fractional anisotropy (FA) using Diffusion Tensor Imaging (DTI), a fully quantitative technique that is capable of ascertaining subtle decline in WM integrity10.
First, we investigated if shared genetic variance between BP and FA measurements was consistent with the pulse-wave encephalopathy (PWE) theory, as previously suggested5, 6. PWE posits the direct and indirect biological effects to explain the regional pattern of BP-related decline in the integrity of cerebral WM11–13. The direct PWE effect suggests that an increase in arterial pulse pressure (PP) can lead to gliosis of periventricular WM, due to mechanical damages associated with increased amplitude of CSF movement5. The indirect PWE effect suggests that an increase in systolic BP (SBP) can lead to focal gliosis in subcortical WM due to stenosis and loss of permeability of small cerebral blood vessels13, 14. Next, we investigated if shared genetic variance between BP and FA was influenced by difference in WM development rates15. Prior studies suggested a connection between the rates of cerebral development and the genetic contribution to the variance of several brain structures16, 17. Development of WM tracts associated with higher cognitive function follow a more protracted trajectory, with larger FA increases per year than sensory and motor tracts15. We therefore investigated if WM tracts that exhibit high maturation rates would be more susceptible to detrimental effects of elevated BP and would therefore show more genetic overlap with the BP measurements.
Methods
Subjects and Measurements
Analyses were performed in 332 (202 females) active participants in the San Antonio Family Heart Study (SAFHS)9 for whom the DTI and BP measurements were available. The participants in SAFHS study are urban-dwelling Mexican-American from large extended pedigrees selected randomly from the community. These subjects are characterized by a relatively adverse cardiovascular risk profile, including increased rates of obesity, dyslipidemia, glucose intolerance, and hyperinsulinemia, when compared with non-Hispanic whites in San Antonio9. Subjects ranged in age from 19 to 79 years of age (47.9±13.3years) and were part of 45 families (9.2±8.1 individuals/family; range 2–35). Among the 400 subjects recruited for this study, 39 were excluded from MRI imaging for: MRI contraindications (N=31), history of neurological illnesses (N=5), or stroke, transient ischemic attack or other major neurological event (N=3). DTI data was not collected for 29 subjects because a subject was unable to complete the MRI session (N=22), scanner malfunction (N=4) and other reasons (N=3). At the time of the collection of BP measurements, 117 subjects (35%, 72 females; average age = 54.8±13.0) were diagnosed with hypertension, including 44 subjects (31 female, average age 58.7±12.2 years) who were observed to be taking antihypertensive medications (all anti-hypertension drugs were directly visually verified and recorded). There was no evidence for hypotension in this cohort with none of the individuals exhibiting blood pressures with of SBP < 90 and/or DBP < 60 mm Hg. Additionally, 133 subjects were obese (BMI>30), 96 subjects had elevated cholesterol levels (total cholesterol levels >200mg/dL), 22 subjects had elevated blood lipids (>150 mg/dL), 63 subjects were reported to have the type II diabetes and 12 subjects were reported to have coronary heart disorders (Table S1, please see http://hyper.ahajournals.org). Alcohol and depression disorders were not exclusion criteria with 26 subjects reporting alcohol dependence and 99 subjects reporting a life time major depressive episode (Table S1). All subjects provided written informed consent on forms approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio (UTHSCSA).
BP Measurements
Collection of the SBP and DBP measurements was detailed in Rutherford et al.2 and proceed the imaging by an average of 3.0±0.8 (maximum = 5.3) years. In short, SBP and DBP measurements were performed using a random-zero sphygmomanometer on the left arm. Three measurements were performed with 5 min intervals and average of the last two measurements was used as trait values. Pulse pressure (PP) was calculated as the difference between SBP and DBP. The average ± stdev SBP, DBP and PP values were 122.6±16.6; 71.3±10.8 and 51.3±14.2, respectively2.
Diffusion tensor imaging and processing
Diffusion tensor imaging was performed at the Research Imaging Institute, UTHSCSA, on a Siemens 3T Trio scanner. A single-shot, single refocusing spin-echo, echo-planar imaging sequence was used to acquire diffusion-weighted data with a spatial resolution of 1.7×1.7×3.0mm. The sequence parameters were: TE/TR=87/8000ms, FOV=200mm, 55 isotropically distributed diffusion weighted directions, two diffusion weighting values, b=0 and 700 s/mm2 and three b=0 (non-diffusion-weighted) images. These parameters were calculated using an optimization technique that maximizes the contrast to noise ratio for FA measurements18.
Details for the processing of DTI scans are discussed elsewhere 3, 19, 20. In short, the tract-based spatial statistics (TBSS) software 21 was used for multi-subject analysis of fractional anisotropy images. FA images were created by fitting the diffusion tensor to the raw diffusion data 22. All FA images were nonlinearly aligned to a group-wise, minimal-deformation target (MDT) brain 23. Next, individual FA images were averaged to produce a group-average anisotropy image. This image is used to create a group-wise skeleton of WM tracts which encodes the medial trajectory of the WM fiber-tracts. Finally, FA values from each image were projected onto the group-wise skeleton of WM structures. This step accounts for residual misalignment among individual WM tracts. FA values are assigned to each point along a skeleton using the peak value found within a 20mm distance perpendicular to the skeleton. The FA values vary rapidly perpendicular to the tract direction but very slowly along the tract direction. By assigning the peak value to the skeleton, this procedure effectively maps the center of individual WM tracts on the skeleton.
The whole-brain (WB) average FA value for each subject was calculated as the average FA value for the entire WM skeleton of about 300·103 voxels. Next, the tract-wise average FA measurements were calculated for 10 major WM tracts (Table 1) as descried in our previous publications3, 20. In short, the population-based, 3D, DTI cerebral WM tract atlas developed in John Hopkins University (JHU) and distributed with the FSL package21 was used to calculate population average diffusion parameter values along the spatial course of the ten, largest (volume ≥5cm3) WM tracts (Table 1). The JHU atlas was non-linearly aligned to the MDT brain and image containing labels for individual tracts was transferred to MDT space using nearest-neighbor interpolation. Per-tract average values were calculated by averaging the values along the tracts in both hemispheres.
Table 1.
White matter tracts used in the analysis (C=Commissural, P=Projection, A=Association)
Tract | Fiber Type | Connections |
---|---|---|
Genu of Corpus Callosum (GCC) | C | Cerebral Hemispheres |
Body of Corpus Callosum (BCC) | C | Cerebral Hemispheres |
Splenium of Corpus Callosum (SCC) | C | Cerebral Hemispheres |
Cingulum (CG) | A | Cingulate Gyrus/Hippocampus |
Corona Radiata (CR) | P | Cortical/Subcortical |
External Capsule (EC) | A | Frontal/Temporal/Occipital |
Internal Capsule (including thalamic radiation) (IC) | P | Subcortical/Brainstem/Cortex |
Superior/Inferior Fronto-Occipital Fasciculi (FO) | A | Frontal/Parietal/Occipital |
Superior Longitudinal Fasciculus (SLF) | A | Frontal/Temporal/Occipital |
Sagittal Stratum (SS) | A/P | Subcortical/Temporal/Occipital |
Genetic analyses
Two sets of analyses were performed to study the magnitude and regional variations in shared genetic variance between the BP and FA using bivariate genetic correlation analyses methods implemented in the SOLAR software package (http://solar.sfbrgenetics.org). First, we analyzed the magnitude of shared genetic effect between BP and WB-FA values. This was followed by calculation of regional bivariate genetic correlations between BP and tract-wise regional FA values. Bivarate genetic analysis calculates the magnitude and significance of genetic correlation coefficient (ρG), which is the proportion of variability due to shared genetic effects. The overall phenotypic correlation (ρP) between two traits A and B (Eq 1) can be expressed using the correlation due to shared additive genetic effects (ρG) and the residual correlation (ρE) due to shared environmental effects.
Eq 1 |
Where, h2A and h2B denote the additive genetic heritabilities for each of the traits i.e. the proportion of the total phenotypic variance that is explained by additive genetic factors. If the genetic correlation coefficient (ρG) is significantly different from zero, then the significant portion of the variance in two traits are considered to be influenced by shared genetic factors 24. All genetic analyses were conducted with age, sex, age*sex, age2, age2*sex included as covariates. The health screening data, Table S1, were not used as covariates because of the loss of statistical power to detect genetic effects due to their potentially overlapping genetic bases24.
Estimating confounding effects of the antihypertensive treatment
Genetic analyses can potentially be confounded by the antihypertensive treatment. We estimated the confounding effects of the antihypertensive drugs using two approaches, as suggested by Cui and colleagues25. First, we used an exclusion approach where the genetic correlation analyses were performed in a cohort that excluded 44 subjects who were taking antihypertensive medication at the time of BP collection (Table S1). Next, we used a phenotype adjustment approach where fixed values of 10 and 5 mm Hg were added to the SBP and DBP values, respectively, for the 44 subjects who were taking antihypertensive medication25. The estimate of the magnitude of the confounding effect was made based on the significance of the difference in the genetic correlation coefficient among the measurements made in the original vs. adjusted cohorts.
Results
WB-FA values showed a significant negative linear trend with both PP and SBP (r2=0.20 and 0.11, respectively, p<10−4) with no significant relationship observed between WB-FA and SBP (Figure S1, please see http://hyper.ahajournals.org). Quantitative genetic analyses estimated that over 50% of the intersubject variance for the whole-brain average FA (WB-FA), PP and SBP and 17% of the variance for the DBP were attributed to additive genetic factors (Table 2). Age and Age2 were significant covariates for PP and WB-FA. Age was a sole significant covariate for the SBP. DBP did not have significant covariates. There were no significant (p<.05) age by sex or age2 by sex interactions detected.
Table 2.
Heritability of WB-FA and Blood Pressure Indices
Trait | h2 (p) | Significant Covariates (p) | Variance Explained by Covariates |
---|---|---|---|
WB-FA | .52 (1E-6) | Age (1.5E-17), Age2 (.002) | 31% |
Pulse-Pressure (PP) | .53 (1E-4) | Age (1E-3), Age2 (1E-4) | 23% |
Systolic blood pressure (SBP) | .63 (1E-6) | Age (1E-3) | 11% |
Diastolic blood pressure (DBP) | .17 (0.04) | None | 0% |
Genetic correlation analyses between BP and the WB-FA values reported that PP and SBP shared 36% (obtained from squaring ρG) and 22% of genetic variance with the WB-FA values, respectively (Table 3). The negative sign of these correlation coefficients suggested that the same genetic factors associated with higher PP and SBP were linked to progressively lower FA values. Genetic correlation between WB-FA and DBP was not significant (Table 3). The estimates of the confounding effects of the antihypertensive were obtained by excluding 44 subjects who were taking antihypertensive medications and by adding 10 and 5 mg Hg to the SBP and DBP values for the treated subjects. There was no significant difference in either sign or magnitude of genetic correlations (Table 3). Therefore, all further, regional analyses were performed in the full pedigree, using the uncorrected BP measurements.
Table 3.
Genetic correlation coefficients ρG (95% confidence interval (CI); p) between whole-brain (WB) FA values and three measurements of arterial BP: PP, SBP and DBP.
WB-FA | PP (CI,p) | SBP (CI;p) | DBP (CI;p) |
---|---|---|---|
ρG (p) | −.60 (−.96,−.24; p=10−3) | −.47 (−.81, −.13; p=.01) | .10 (−.52,.72;p=.8) |
ρ*G (p) | −.62 (−1.0, −.24; p=10−3) | −.45 (−.81, −.09; p=.02) | .12 (−.05,.74; p=.7) |
ρG (p)† | −.64 (−1.0, −.22; p=10−3) | −.43 (−.79, −.07; p=.03) | .08 (−.50,.64; p=.7) |
Calculated following the exclusion of 44 subjects taking antihypertensive medications.
Calculated following the addition of 10 and 5 mm Hg to the SBP and DBP measurements for subjects taking antihypertensive medications.
Genetic correlation analyses between BP and the tract-wise FA values (Table 4) indicated that six out of ten WM tracts (GCC, BCC, SCC, FO, SLF and SS) showed a statistically significant (p≤0.05) genetic correlation with PP. Genetic correlation failed to reach statistical significance (0.05≤p≤0.10) for three more tracts: cingulum, CR and EC (Table 4). Genetic correlation coefficients for FA of four tracts (GCC, BCC, FO and SS) showed a statistically significant (p≤0.05) genetic correlation with SBP and approached significance (p≤0.10) for SCC (Table 4). There were no significant or suggestive genetic correlation coefficients observed for the genetic correlation coefficients with DBP (Table 4)
Table 4.
Heritability (h2), the rates of maturation and senescence* and the genetic correlation coefficients ρG (95% confidence interval (CI); p) were calculated for ten major WM tracts.
WM Tract | h2(p) | Rate of maturation (FA/year)* | ρG (CI; p) PP | ρG (CI;p) SBP | ρG (CI;p) DBP |
---|---|---|---|---|---|
Genu of Corpus Callosum (GCC) | .66 (1E-9) | 21.3·10−4 | −.59 (−.90, −.30; 10−4) | −.55 (−.85, −.25; 10−3) | −.17(−1.0, 0.83; 50) |
Body of Corpus Callosum (BCC) | .54 (1E-7) | 14.7·10−4 | −.44 (−.80, −.08; .01) | −.61(−.97, −.08;10−4) | −.32(−.92,.28.30) |
Splenium of Corpus Callosum (SCC) | .57 (1E-7) | 8.4·10−4 | −.43 (−.85, −.01;.04) | −.33 (−.71,.05;.10) | −.05 (−1.0, 1.0;.87) |
Cingulum | .34 (1E-3) | 13.6·10−4 | −.39 (−.85,.07; .10) | −.18 (−.64,.28; .40) | .37(−.23,.97;.30) |
Corona Radiata (CR) | .56 (1E-7) | 2.5·10−4 | −.33 (−.71, .05; .08) | −.19 (−.55, .17;.30) | .23 (−.70,1.0;.46) |
External Capsule (EC) | .43 (1E-5) | 0.3·10−4 | −.25 (−.65, .15;.21) | −.19 (−.57,.19;.30) | .21(−.87,1.0;.54) |
Internal Capsule (including thalamic radiation) (IC) | .43 (1E-6) | 4.7·10−4 | −.41 (−.93,.11;.09) | −.19(−.63,.25;.40) | .42(−.14,.98;.28) |
Frontal-Occipital (FO) | .41 (1E-6) | 10.9·10−4 | −.45(−.85, −.05;.03) | −.43(−.85, −.01;.05) | −.16 (−1.0,1.0;.65) |
Superior Longitudinal Fasciculus (SLF) | .58 (1E-7) | 6.8·10−4 | −.38 (−.76, .00,.04) | −.29 (−.67,.10;.20) | −.11 (−1.0,1.0;.72) |
Sagittal Stratum (SS) | .40 (1E-4) | 12.4·10−4 | −.67 (−1.0, −.29; 10−4) | −.51(−.91, −.30; 0.01) | .21 (−.90, 1.0;.54) |
Data taken from20.
The plot of the genetic correlation coefficients (ρG) for ten WM tracts versus tract-wise rates of cerebral maturation, taken from20 (Figure 1) demonstrate that WM bundles with higher rates of maturation shared a progressively higher genetic overlap with both PP and SBP. Linear regression analysis reported that this relationship was statistically significant for both PP and SBP (Pearson’s r2=.55 and 0.57; p≤0.01, respectively) (Figure 1) but not for DBP (Pearson’s r2= .23; p=0.16).
Figure 1.
The tract-wise genetic correlation coefficients (ρG) for PP (top graph) and SBP (bottom graph) are plotted versus tract-wise rates of cerebral maturation (Table 4) in FA units/year taken from20. Linear regression analyses (solid lines) indicated that the by-tract variability in the magnitude of genetic overlap was significantly correlated with the by-tract rates of FA increase during maturation for both PP and SBP (Pearson’s r=0.74 and 0.76; p≤0.01)
Discussion
This study in a large, well-characterized sample of Mexican-American participants in the San Antonio Family Heart Study (SAFHS)9 demonstrated that the arterial pulse pressure (PP) and systolic blood pressure (SBP) shared 36% and 22% of genetic variance with the whole-brain (WB) fractional anisotropy (FA) of white matter (WM), respectively. In the past, the integrity of cerebral WM was commonly assessed using the T2-hyperintense white matter (HWM) lesion imaging techniques5–8. HWM lesions are the regions of accumulation of extra-cellular water due to focal degradation of the myelin sheath14 and their volume is an important neuroimaging marker of cerebral integrity26. DTI has an advantage over HWM-imaging techniques because it is capable of ascertaining subtle WM damage that precedes formation of HWM lesions10. Several recent studies confirmed that DTI is a sensitive neuroimaging marker of white matter integrity in hypertensive individuals10, 27, 28. Specifically, FA values were inversely correlated with the arterial pulse pressure PP and systolic BP in both normotensive and hypertensive individuals27
The PP shared more genetic variance with the WB-FA values than SBP. This is consistent with the pulse-wave encephalopathy (PWE) theory12, 13, which suggests that elevation in the arterial pulsativity can lead to cerebral injury even in normotensive individuals27. Similar pattern was observed in a prior whole-genome linkage study in this population where PP and the volume of HWM lesion shared significant genetic loci, while the association between SBP and HWM lesion volume only reached suggestive signficance5. The regional patterns of genetic overlap between BP and FA were in-agreement with the direct and indirect mechanisms of BP-related cerebral injury as described by the PWE theory. The direct mechanism is primarily responsible for the gliosis of the periventricular WM12, 13. This explains the high negative (ρG =−.43 to −.67) genetic correlation between PP and periventricular WM tracts. The highest genetic correlation was observed for the sagittal stratum (SS), which is located in the area that is especially susceptible to the periventricular gliosis27. The indirect mechanism of the PWE theory is suggested to be responsible for formation of subcortical WM lesions, most commonly observed in the frontal lobe11, 27. This may explain high genetic correlations observed between the SBP and the FA of the genu and the body of CC, as these tracts contain commissural fibers connecting frontal lobes. The biological pathway of the indirect mechanisms remains unclear. Stenosis of small cerebral vessels, especially in the watershed areas29 and high metabolic demands of oligodendrocytes of associative WM contribute to a high vulnerability of the frontal WM to the indirect PWE mechanism30. Oligodendrocytes of the associative frontal WM are among the most metabolically active cells in the adult CNS and therefore, are highly susceptible to damages from hypoxia30. In addition, the oligodendrocytes of the associated, frontal WM tracts have reduced rates (per axonal-segment) of myelin production and repair31 and this is thought to be responsible for the protracted age-related myelination and sharp age-related decline20.
Previous findings suggested that the protracted development and high metabolic demands of associative WM make it more vulnerable to age-related neurodegeneration than sensory and motor WM19, 27, 32. In agreement with these findings, our results showed that WM tracts that continue to meylinate into adulthood and therefore show higher age-related maturation rates shared progressively more genetic overlap with PP and SBP. In fact, over 50% of regional variability in shared genetic variance was explained by the regional rates of cerebral maturation. We interpret this finding as the evidence for genotype-by-age interaction with protracted development of associative WM contributing to its higher susceptibility to the neurodegeneration associated with elevated PP and SBP.
Unlike PP and SBP, significant genetic correlations were not observed between DBP and FA. However, given the lower observed heritability of DBP, the current study is relatively underpowered and therefore can fail to identify genetic correlations for this pair of phenotypes. The statistical power of the current study may also have been limited to detect significant genetic correlation for track-wise measurements of FA, where the magnitude of genetic correlation coefficients for several analyses approached statistical significance. Therefore, the lack of significant genetic correlations cannot be interpreted as evidence against that those pleiotropic relationships exist. Additionally, our study examined Mexican Americans, a population with significant Native American admixture. If relatively rare variants are involved in the determination of quantitative variance, we may expect considerable differences in the degree of shared genetic variance in other populations, such as European Americans33.
Perspective
Our findings in a population characterized by an adverse cardiovascular risk profile demonstrated that genetic factors responsible for elevation in arterial PP and SBP were also responsible for declining integrity of cerebral WM. In agreement with PWE theory, the highest genetic association with WM integrity was observed for PP. Further, our data demonstrated that associative WM tracts that facilitate high-order cognitive functioning showed higher vulnerability to the elevated PP and SBP than motor and sensory WM tracts. The statistical power of this study was not sufficient to localize the individual genes responsible for the pleiotropy between BP and FA but previous studies in this population provide a likely candidate: selectin genes2, 5, 6. The region harboring the constellation of selectin genes (SELP, SELL, and SELE) has been identified as a region of significant linkage (LOD=3.82) between PP and HWM volume. In particular, the adhesion molecule P-selectin34 is a marker of potential endothelial dysfunction that has been implicated as a risk factor in essential hypertension35, 36 and stroke35, 37. Increased blood levels of P-selectin have been implicated in formation of atherosclerotic plaque, loss of vascular reactivity and increase in arterial pulsativity and SBP35, 37. In addition, platelet-derived gene expression levels of SELP were shown to be strongly and positively correlated with arterial BP 38, 39
Limitations
Our data indicates that a genotype-by-age interaction is potentially responsible for genetic overlap between BP and FA. Hence, it may be useful to explicitly allow for the potential influences of genotype by age interactions. While advanced statistical genetic methods for family based data allow for the formal detection of such interactions within cross-sectional data, longitudinal family studies will have much greater power to localize and ultimately identify the specific genes involved in intersubject differences in the rates of WM atrophy. Therefore, further research is needed to confirm the cross-sectional trends observed here using a longitudinal design.
A potential limitation of this study is that the collection of BP measurements preceded the acquisition of brain images by 3.0±0.8 (maximum = 5.3) years. Individual subjects could have experienced a rise in BP during the period between BP and brain assessment suggesting caution when interpreting these findings.
Supplementary Material
Acknowledgments
Sources of funding
This research was supported by National Institute of Biomedical Imaging and Bioengineering (K01 EB006395) grant to P.K., the National Heart Lung and Blood Institute (P01HL045522) to J.B., and the National Institute of Mental Health (R37MH059490 and R01MH078111) to JB and (R01MH0708143 and R01MH083824) to D.G.
Footnotes
Conflicts of Interest
Authors have no conflicts of interest to disclose.
References
- 1.He W, Sengupta M, Velkoff V, DeBarros K. Current population reports. Special studies. 65+ in the United States: 2005. US Census Report. 2006 http://www.census.gov/prod/2006pubs/p23-209.pdf.
- 2.Rutherford S, Cai G, Lopez-Alvarenga JC, Kent JW, Voruganti VS, Proffitt JM, Curran JE, Johnson MP, Dyer TD, Jowett JB, Bastarrachea RA, Atwood LD, Goring HH, Maccluer JW, Moses EK, Blangero J, Comuzzie AG, Cole SA. A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study. Am J Hum Genet. 2007;81:744–755. doi: 10.1086/521151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kochunov P, Glahn D, Lancaster J, Wincker P, Smith S, Thompson P, Almasy L, Duggirala R, Fox P, Blangero J. Genetics of microstructure of cerebral white matter using diffusion tensor imaging. Neuroimage. 2010;15:1109–1116. doi: 10.1016/j.neuroimage.2010.01.078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Brouwer RM, Mandl RC, Peper JS, van Baal GC, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of DTI and MTR in nine-year-old children. Neuroimage. 2010;53:1085–1092. doi: 10.1016/j.neuroimage.2010.03.017. [DOI] [PubMed] [Google Scholar]
- 5.Kochunov P, Glahn D, Lancaster J, Winkler A, Kent J, Olvera R, Cole S, Dyer T, Almasy L, Duggirala R, Fox P, Blangero J. Whole Brain and Regional Hyperintense White Matter Volume and Blood Pressure: Overlap of Genetic Loci produced by Bivariate, Whole-Genome Linkage Analyses. Stroke. 2010;41:2137–2142. doi: 10.1161/STROKEAHA.110.590943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kochunov P, Glahn D, Winkler A, Duggirala R, Olvera R, Cole SA, Dyer TD, Almasy L, Fox P, Blangero J. Analysis of Genetic Variability And Whole Genome Linkage Of Whole-Brain, Subcortical And Ependymal Hyperintense White Matter Volume. Stroke. 2009;40:3685–3690. doi: 10.1161/STROKEAHA.109.565390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.DeStefano AL, Atwood LD, Massaro JM, Heard-Costa N, Beiser A, Au R, Wolf PA, DeCarli C. Genome-wide scan for white matter hyperintensity: the Framingham Heart Study. Stroke. 2006;37:77–81. doi: 10.1161/01.STR.0000196987.68770.b3. [DOI] [PubMed] [Google Scholar]
- 8.Turner ST, Fornage M, Jack CR, Jr, Mosley TH, Kardia SL, Boerwinkle E, de Andrade M. Genomic susceptibility loci for brain atrophy in hypertensive sibships from the GENOA study. Hypertension. 2005;45:793–798. doi: 10.1161/01.HYP.0000154685.54766.2d. [DOI] [PubMed] [Google Scholar]
- 9.Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation. 1996;94:2159–2170. doi: 10.1161/01.cir.94.9.2159. [DOI] [PubMed] [Google Scholar]
- 10.Maclullich AM, Ferguson KJ, Reid LM, Deary IJ, Starr JM, Seckl JR, Bastin ME, Wardlaw JM. Higher systolic blood pressure is associated with increased water diffusivity in normal-appearing white matter. Stroke. 2009;40:3869–3871. doi: 10.1161/STROKEAHA.109.547877. [DOI] [PubMed] [Google Scholar]
- 11.Bateman GA. Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer’s disease, vascular dementia and normal pressure hydrocephalus. Med Hypotheses. 2004;62:182–187. doi: 10.1016/S0306-9877(03)00330-X. [DOI] [PubMed] [Google Scholar]
- 12.Henry Feugeas MC, De Marco G, Peretti, Godon-Hardy S, Fredy D, Claeys ES. Age-related cerebral white matter changes and pulse-wave encephalopathy: observations with three-dimensional MRI. Magn Reson Imaging. 2005;23:929–937. doi: 10.1016/j.mri.2005.09.002. [DOI] [PubMed] [Google Scholar]
- 13.Bateman GA. Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal-pressure hydrocephalus. Neuroradiology. 2002;44:740–748. doi: 10.1007/s00234-002-0812-0. [DOI] [PubMed] [Google Scholar]
- 14.Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683–1689. doi: 10.1212/wnl.43.9.1683. [DOI] [PubMed] [Google Scholar]
- 15.Flechsig P. Developmental (myelogenetic) localisation of the cerebral cortex in the human. Lancet. 1901;158:1027–1030. [Google Scholar]
- 16.Brun C, Lepore N, Pennec X, Chou YY, Lee AD, Barysheva M, de Zubicaray G, Meredith M, McMahon K, Wright MJ, Toga AW, Thompson PM. A tensor-based morphometry study of genetic influences on brain structure using a new fluid registration method. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 2008;11:914–921. doi: 10.1007/978-3-540-85990-1_110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kochunov P, Castro C, Davis D, Dudley D, Brewer J, Zhang Y, Kroenke CD, Purdy D, Fox PT, Simerly C, Schatten G. Mapping primary gyrogenesis during fetal development in primate brains: high-resolution in utero structural MRI study of fetal brain development in pregnant baboons. Frontiers in Neurogenesis. 2010;4 doi: 10.3389/fnins.2010.00020. doi: 10.3389.fnins.2010.00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med. 1999;42:515–525. [PubMed] [Google Scholar]
- 19.Kochunov P, Thompson PM, Lancaster JL, Bartzokis G, Smith S, Coyle T, Royall DR, Laird A, Fox PT. Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage. 2007;35:478–487. doi: 10.1016/j.neuroimage.2006.12.021. [DOI] [PubMed] [Google Scholar]
- 20.Kochunov P, Williamson D, Lancaster J, Fox P, Cornell J, Blangero J, Glahn D. Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiol Aging. 2010 doi: 10.1016/j.neurobiolaging.2010.01.014. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31:1487–1505. doi: 10.1016/j.neuroimage.2006.02.024. [DOI] [PubMed] [Google Scholar]
- 22.Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–155. doi: 10.1002/hbm.10062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kochunov P, Lancaster JL, Thompson P, Woods R, Mazziotta J, Hardies J, Fox P. Regional spatial normalization: toward an optimal target. J Comput Assist Tomogr. 2001;25:805–816. doi: 10.1097/00004728-200109000-00023. [DOI] [PubMed] [Google Scholar]
- 24.Almasy L, Dyer TD, Blangero J. Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol. 1997;14:953–958. doi: 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
- 25.Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 2003;41:207–210. doi: 10.1161/01.hyp.0000044938.94050.e3. [DOI] [PubMed] [Google Scholar]
- 26.Kochunov P, Thompson PM, Coyle TR, Lancaster JL, Kochunov V, Royall D, Mangin JF, Riviere D, Fox PT. Relationship among neuroimaging indices of cerebral health during normal aging. Hum Brain Mapp. 2008;29:36–45. doi: 10.1002/hbm.20369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kennedy KM, Raz N. Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res. 2009;1297:41–56. doi: 10.1016/j.brainres.2009.08.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Nitkunan A, Charlton RA, McIntyre DJ, Barrick TR, Howe FA, Markus HS. Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease. Magn Reson Med. 2008;59:528–534. doi: 10.1002/mrm.21461. [DOI] [PubMed] [Google Scholar]
- 29.Minkner K, Lovblad KO, Yilmaz H, Alimenti A, Sekoranja L, Delavelle J, Sztajzel R, Rufenacht DA. White matter lesions in watershed territories studied with MRI and parenchymography: a comparative study. Neuroradiology. 2005;47:425–430. doi: 10.1007/s00234-005-1358-8. [DOI] [PubMed] [Google Scholar]
- 30.Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease. Neurobiol Aging. 2004;25:843–851. doi: 10.1016/j.neurobiolaging.2003.09.005. [DOI] [PubMed] [Google Scholar]
- 31.Hof PR, Cox K, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer’s disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol. 1990;301:44–54. doi: 10.1002/cne.903010105. [DOI] [PubMed] [Google Scholar]
- 32.Kochunov P, Coyle T, Lancaster J, Robin DA, Hardies J, Kochunov V, Bartzokis G, Stanley J, Royall D, Schlosser AE, Null M, Fox PT. Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging. Neuroimage. 2009;49:1190–1199. doi: 10.1016/j.neuroimage.2009.09.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Blangero J, Williams JT, Almasy L. Novel family-based approaches to genetic risk in thrombosis. J Thromb Haemost. 2003;1:1391–1397. doi: 10.1046/j.1538-7836.2003.00310.x. [DOI] [PubMed] [Google Scholar]
- 34.Herrmann SM, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets JB, Arveiler D, Luc G, Cambien F. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet. 1998;7:1277–1284. doi: 10.1093/hmg/7.8.1277. [DOI] [PubMed] [Google Scholar]
- 35.Zee RY, Cook NR, Cheng S, Reynolds R, Erlich HA, Lindpaintner K, Ridker PM. Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Genet. 2004;13:389–396. doi: 10.1093/hmg/ddh039. [DOI] [PubMed] [Google Scholar]
- 36.Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 2003;24:2166–2179. doi: 10.1016/j.ehj.2003.08.021. [DOI] [PubMed] [Google Scholar]
- 37.Preston RA, Coffey JO, Materson BJ, Ledford M, Alonso AB. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. Atherosclerosis. 2007;192:148–154. doi: 10.1016/j.atherosclerosis.2006.04.028. [DOI] [PubMed] [Google Scholar]
- 38.Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O’Connell P, Stern MP. A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am J Hum Genet. 2000;66:1237–1245. doi: 10.1086/302849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Goring HH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, Cole SA, Jowett JB, Abraham LJ, Rainwater DL, Comuzzie AG, Mahaney MC, Almasy L, MacCluer JW, Kissebah AH, Collier GR, Moses EK, Blangero J. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet. 2007;39:1208–1216. doi: 10.1038/ng2119. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.